S6 shows that endogenous IL - 4 and IFN - gamma do not effect Foxp3 expression in naive CD4 + T cells of CbfbF / F CD4 - cre and CbfbF / F control mice, which were stimulated with anti - CD3 and anti - CD28 mAbs, IL - 2 and TGF - beta in the absence or presence of anti - IL - 4 and anti - IFN - gamma neutralizing mAbs.	"IL - 4	25	31	Protein"	"IFN - gamma	36	47	Protein"	"Foxp3	62	67	Protein"	"CD4	88	91	Protein"	"CbfbF	105	110	Protein"	"CD4 - cre	115	124	Protein"	"CbfbF	129	134	Protein"	"CD3	187	190	Protein"	"CD28	202	206	Protein"	"IL - 2	213	219	Protein"	"TGF - beta	224	234	Protein"	"IL - 4	272	278	Protein"	"IFN - gamma	290	301	Protein"	"[{""token"": ""IL - 4"", ""start_span"": 25, ""end_span"": 31, ""type"": ""Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 36, ""end_span"": 47, ""type"": ""Protein""}, {""token"": ""Foxp3"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 88, ""end_span"": 91, ""type"": ""Protein""}, {""token"": ""CbfbF"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Protein""}, {""token"": ""CD4 - cre"", ""start_span"": 115, ""end_span"": 124, ""type"": ""Protein""}, {""token"": ""CbfbF"", ""start_span"": 129, ""end_span"": 134, ""type"": ""Protein""}, {""token"": ""CD3"", ""start_span"": 187, ""end_span"": 190, ""type"": ""Protein""}, {""token"": ""CD28"", ""start_span"": 202, ""end_span"": 206, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 213, ""end_span"": 219, ""type"": ""Protein""}, {""token"": ""TGF - beta"", ""start_span"": 224, ""end_span"": 234, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 272, ""end_span"": 278, ""type"": ""Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 290, ""end_span"": 301, ""type"": ""Protein""}]"
The physiological relevance of Tat cross talk with NF - kappaB was demonstrated in the HIV - 1 infection of human monocytes, where HIV - 1 - encoded Tat protein counteracted post - activation turn off of NF - kappaB, as shown by: ( i) sustained NF - kappaB activity by Tat in presence of newly synthesized IkappaB - alpha; ( ii) coimmunoprecipitation of Tat with IkappaB - alpha and p65; ( iii) induction of MIP - 1alpha expression dependent on Tat and p65; ( iv) Tat occupancy of the MIP - 1alpha NF - kappaB enhancer associated with increased recruitment of p65.	"Tat	31	34	Protein"	"Tat	149	152	Protein"	"Tat	269	272	Protein"	"IkappaB - alpha	306	321	Protein"	"Tat	354	357	Protein"	"IkappaB - alpha	363	378	Protein"	"p65	383	386	Protein"	"MIP - 1alpha	408	420	Protein"	"Tat	445	448	Protein"	"p65	453	456	Protein"	"Tat	464	467	Protein"	"MIP - 1alpha	485	497	Protein"	"p65	560	563	Protein"	"[{""token"": ""Tat"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Protein""}, {""token"": ""Tat"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Protein""}, {""token"": ""Tat"", ""start_span"": 269, ""end_span"": 272, ""type"": ""Protein""}, {""token"": ""IkappaB - alpha"", ""start_span"": 306, ""end_span"": 321, ""type"": ""Protein""}, {""token"": ""Tat"", ""start_span"": 354, ""end_span"": 357, ""type"": ""Protein""}, {""token"": ""IkappaB - alpha"", ""start_span"": 363, ""end_span"": 378, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 383, ""end_span"": 386, ""type"": ""Protein""}, {""token"": ""MIP - 1alpha"", ""start_span"": 408, ""end_span"": 420, ""type"": ""Protein""}, {""token"": ""Tat"", ""start_span"": 445, ""end_span"": 448, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 453, ""end_span"": 456, ""type"": ""Protein""}, {""token"": ""Tat"", ""start_span"": 464, ""end_span"": 467, ""type"": ""Protein""}, {""token"": ""MIP - 1alpha"", ""start_span"": 485, ""end_span"": 497, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 560, ""end_span"": 563, ""type"": ""Protein""}]"
